Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Epidemiologist who He has forecast About whether there is a connection between COVID-19 vaccines And “turbinoid cancer” in young people, and the chief epidemiologist works in A a company Which sells the drug ivermectin along with reviews claiming its effectiveness as a cancer treatment, was appointed by President Donald Trump to a key position overseeing the National Cancer Program.
Harvey Reisch, professor emeritus of epidemiology at the Yale School of Public Health, announced his appointment as chair of the committee President’s Cancer Panel On X Earlier this month. feathers Profile page Yale’s website was also updated to read, “In November 2025, President Trump appointed Dr. Risch to chair the President’s Commission on Cancer.”
No official announcement has been made by the President or the White House, and the list of current members on the Cancer Panel’s website does not include Resch. The White House, the Department of Health and Human Services, the Cancer Commission, and Risch did not respond to requests for comment.
In his new position, Resch will oversee a group charged with monitoring “the development and implementation of National Cancer Program activities and reporting to the President on progress, effectiveness, and opportunities for improvement,” according to the Cancer Commission’s website.
In addition to lending credibility to unproven treatments for Covid-19 such as hydroxychloroquine and ivermectin, he has promoted the former in… Congressional testimony– Risch recently wondered whether COVID-19 vaccines cause “turbo cancer” in some people. Now experts worry it could derail important research into cancer causes and treatments.
“His presence on the committee charged with monitoring the progress of efforts to improve cancer treatment and making recommendations to the president is a disaster for cancer patients, because he will introduce conspiracy theories, pseudoscience and false claims about cancer into the committee’s reports,” says David Gorsky, MD, a surgical oncologist.
Another expert, who spoke to WIRED on the condition of anonymity because they feared retaliation for speaking out about a Trump appointee, warned that they were concerned that his conspiracy-bordering beliefs might seep into the National Cancer Program, a long-standing effort to coordinate funding for critical cancer research and training.
“I’m really concerned that we’re going to see ivermectin promoted for cancer treatment at the federal level,” the doctor, who closely tracks the spread of medical misinformation, told WIRED.